These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15693894)

  • 1. The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study.
    Pillai G; Cook N; Turley H; Leek RD; Blasquez C; Pezzella F; Harris AL; Gatter KC
    Histopathology; 2005 Feb; 46(2):209-16. PubMed ID: 15693894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study.
    Zhang Y; Pillai G; Gatter K; Blázquez C; Turley H; Pezzella F; Watt SM
    Hum Pathol; 2005 Jul; 36(7):797-805. PubMed ID: 16084950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
    Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
    Hematol Oncol; 2008 Dec; 26(4):219-24. PubMed ID: 18461646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated KDR can be located in the nucleus of neoplastic cells.
    Blazquez C; Cook N; Micklem K; Harris AL; Gatter KC; Pezzella F
    Cell Res; 2006 Jan; 16(1):93-8. PubMed ID: 16467880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.
    Imai N; Shikami M; Miwa H; Suganuma K; Hiramatsu A; Watarai M; Satoh A; Itoh M; Imamura A; Mihara H; Nitta M
    Br J Haematol; 2006 Dec; 135(5):673-82. PubMed ID: 17107349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
    J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
    Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
    Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling.
    Mattila E; Auvinen K; Salmi M; Ivaska J
    J Cell Sci; 2008 Nov; 121(Pt 21):3570-80. PubMed ID: 18840653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
    Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
    Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis.
    Svensson S; Jirström K; Rydén L; Roos G; Emdin S; Ostrowski MC; Landberg G
    Oncogene; 2005 Jun; 24(27):4370-9. PubMed ID: 15806151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
    Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib.
    Solowiej J; Bergqvist S; McTigue MA; Marrone T; Quenzer T; Cobbs M; Ryan K; Kania RS; Diehl W; Murray BW
    Biochemistry; 2009 Jul; 48(29):7019-31. PubMed ID: 19526984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma.
    Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M
    Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.
    Piccaluga PP; Agostinelli C; Califano A; Carbone A; Fantoni L; Ferrari S; Gazzola A; Gloghini A; Righi S; Rossi M; Tagliafico E; Zinzani PL; Zupo S; Baccarani M; Pileri SA
    Cancer Res; 2007 Nov; 67(22):10703-10. PubMed ID: 18006812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
    Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
    Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
    Higgins KJ; Abdelrahim M; Liu S; Yoon K; Safe S
    Biochem Biophys Res Commun; 2006 Jun; 345(1):292-301. PubMed ID: 16678129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.